Post-transcriptional divergence in the regulation of CAT-2A, CAT-2B and iNOS expression by dexamethasone in vascular smooth muscle cells

Amino Acids

Volumn 43, Issue 2, 2012, Pages 667-676

  Thakur, Shori ^a   Baydoun, Anwar R ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Cationic amino acid transporters; Dexamethasone; Inducible nitric oxide synthase; NF jB; Septic shock; Smooth muscle cells

Indexed keywords

ARGININE; CAT 2A PROTEIN; CAT 2B PROTEIN; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CAT 2A GENE; CAT 2B GENE; CONTROLLED STUDY; GENE; GENE EXPRESSION; INOS GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; REGULATORY MECHANISM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARGININE; CATIONIC AMINO ACID TRANSPORTER 1; CATIONIC AMINO ACID TRANSPORTER 2; CELLS, CULTURED; DEXAMETHASONE; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; LEUPEPTINS; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 84864740069     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1115-8     Document Type: Article

References (38)

1. Adcock IM, Ito K (2000) Molecular mechanisms of corticosteroid actions. Monaldi Arch Chest Dis 55:256-266
2. Baydoun AR, Wileman SM, Wheeler-Jones CP, Marber MS, Mann GE, Pearson JD, Closs EI (1999) Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem J 344:265-272
3. Closs EI, Lyons CR, Kelly C, Cunningham JM (1993a) Characterization of the third member of the MCAT family of cationic amino acid transporters. Identification of a domain that determines the transport properties of the MCAT proteins. J Biol Chem 268:20796-20800
4. Closs EI, Albritton LM, Kim JW, Cunningham JM (1993b) Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. J Biol Chem 268:7538-7544
5. Closs EI, Boissel JP, Habermeier A, Rotmann A (2006) Structure and function of cationic amino acid transporters (CATs). J Membr Biol 213:67-77
6. Cui Z, Tuladhar R, Hart SL, Marber MS, Pearson JD, Baydoun AR (2005) Rate of transport of L-arginine is independent of the expression of inducible nitric oxide synthase in HEK 293 cells. Nitric Oxide 12:21-30
7. De Vera ME, Taylor BS, Wang Q, Shapiro RA, Billiar TR, Geller DA (1997) Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B. Am J Physiol 273:G1290-G1296
8. Durante W, Liao L, Schafer AI (1995) Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. Am J Physiol 268:H1158-H1164
9. Eberhardt W, Kunz D, Pfeilschifter J (1994) Pyrrolidine dithiocarbamate differentially affects interleukin 1 beta-and cAMPinduced nitric oxide synthase expression in rat renal mesangial cells. Biochem Biophys Res Commun 200:163-170
10. Finley KD, Kakuda DK, Barrieux A, Kleeman J, Huynh PD, Macleod CL (1995) A mammalian arginine/lysine transporter uses multiple promoters. Proc Natl Acad Sci USA 92:9378-9382
11. Hammermann R, Dreissig MD, Mossner J, Fuhrmann M, Berrino L, Gothert M, Racke K (2000) Nuclear factor-kappaB mediates simultaneous induction of inducible nitric-oxide synthase and up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages. Mol Pharmacol 58:1294-1302
12. Hart SL, Arancibia-Carcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Harbottle RP, Knight AM, Larkin DF, Levinsky RJ, Seymour LW, Thrasher AJ, Kinnon C (1998) Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther 9:575-585
13. Hattori Y, Kasai K, Gross SS (1999) Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 276:H2020-H2028
14. Huang CJ, Tsai PS, Lu YT, Cheng CR, Stevens BR, Skimming JW, Pan WH (2004) NF-kappaB involvement in the induction of high affinity CAT-2 in lipopolysaccharide-stimulated rat lungs. Acta Anaesthesiol Scand 48:992-1002
15. Katsuyama K, Shichiri M, Marumo F, Hirata Y (1998) Role of nuclear factor-kappaB activation in cytokine-and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Endocrinology 139:4506-4512
16. Katsuyama K, Shichiri M, Kato H, Imai T, Marumo F, Hirata Y (1999) Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology 140:2183-2190
17. Kilbourn RG, Griffith OW (1992) Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84:827-831
18. Kim JW, Closs EI, Albritton LM, Cunningham JM (1991) Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352:725-728
19. Kleinert H, Euchenhofer C, IhrigBiedert I, Forstermann U (1996) Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 49:15-21
20. Knowles RG, Salter M, Brooks SL, Moncada S (1990) Antiinflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 172:1042-1048
21. Kunz D, Walker G, Eberhardt W, Pfeilschifter J (1996) Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci USA 93:255-259
22. Lin WC, Tsai PS, Huang CJ (2005) Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A. Anesth Analg 101:226-232
23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25:402-408
24. Matsumura M, Kakishita H, Suzuki M, Banba N, Hattori Y (2001) Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaBin vascular smoothmuscle cells.LifeSci 69:1067-1077
25. Nicholson B, Manner CK, Kleeman J, MacLeod CL (2001) Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J Biol Chem 276:15881-15885
26. Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hsieh CM, Kourembanas S, Lee ME (1994) Transforming growth factor-beta1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1beta in rat smooth muscle cells. J Biol Chem 269:14595-14600
27. Reade MC, Clark MF, Young JD, Boyd CA (2002) Increased cationic amino acid flux through a newly expressed transporter in cells overproducing nitric oxide from patients with septic shock. Clin Sci 102:645-650
28. Schott CA, Gray GA, Stoclet J-C (1993a) Dependence of endotoxininduced vascular hyporeactivity on extracellular L-arginine. Br J Pharmacol 108:38-43
29. Schott CA, Vetrovsky P, Stoclet J-C (1993b) Cationic amino acids inhibit the effects of L-arginine in rat aorta exposed to lipopolysaccharide. Eur J Pharmacol 236:155-157
30. Torrie LJ, MacKenzie CJ, Paul A, Plevin R (2001) Hydrogen peroxide-mediated inhibition of lipopolysaccharide-stimulated inhibitory kappa B kinase activity in rat aortic smooth muscle cells. Br J Pharmacol 134:393-401
31. Visigalli R, Bussolati O, Sala R, Barilli A, Rotoli BM, Parolari A, Alamanni F, Gazzola GC, Dall'Asta V (2004) The stimulation of arginine transport by TNFalpha in human endothelial cells depends on NF-kappaB activation. Biochim Biophys Acta 1664:45-52
32. Walker G, Pfeilschifter J, Kunz D (1997) Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J Biol Chem 272:16679-16687
33. Walker G, Pfeilschifter J, Otten U, Kunz D (2001) Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I. Biochim Biophys Acta 1568:216-224
34. Wang H, Kavanaugh MP, North RA, Kabat D (1991) Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 352:729-731
35. Wileman SM, Mann GE, Baydoun AR (1995) Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide. Br J Pharmacol 116:3243-3250
36. Wileman SM, Mann GE, Pearson JD, Baydoun AR (2003) Role of L-citrulline transport in nitric oxide synthesis in rat aortic smooth muscle cells activated with LPS and interferon-gamma. Br J Pharmacol 140:179-185
37. Xie Q, Kashiwabara Y, Nathan C (1994) Role of transcription factor NF-kappaB/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4708
38. Yang CH, Tsai PS, Lee JJ, Huang CH, Huang CJ (2005) NF-kappaB inhibitors stabilize the mRNA of high-affinity type-2 cationic amino acid transporter in LPS-stimulated rat liver. Acta Anaesthesiol Scand 49:468-476